Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (26)
Hongyun Zhang, Ziying Wang, Guangqiang Wang, Xin Song, Yangyang Qian, Zhuan Liao, Li Sui, Lianzhong Ai & Yongjun Xia. (2023) Understanding the Connection between Gut Homeostasis and Psychological Stress. The Journal of Nutrition 153:4, pages 924-939.
Crossref
Crossref
Elena Körner & Axel Lorentz. (2023) Fecal microbiota transplantation in patients with irritable bowel syndrome: an overview of current studies. Journal of Applied Microbiology 134:3.
Crossref
Crossref
Justine Marchix, Lucille Quénéhervé, Philippe Bordron, Philippe Aubert, Tony Durand, Thibauld Oullier, Claude Blondeau, Samira Ait Abdellah, Stanislas Bruley des Varannes, Samuel Chaffron, Emmanuel Coron & Michel Neunlist. (2023) Could the Microbiota Be a Predictive Factor for the Clinical Response to Probiotic Supplementation in IBS-D? A Cohort Study. Microorganisms 11:2, pages 277.
Crossref
Crossref
Qian Chen, Hua Zhang, Chang-Yue Sun, Qing-Ying He, Rui-Rong Zhang, Bin-Fei Luo, Zi-Hao Zhou & Xiao-Fan Chen. (2023) Evaluation of two laboratory model methods for diarrheal irritable bowel syndrome. Molecular Medicine 29:1.
Crossref
Crossref
John A. Damianos & Eric D. Shah. 2023. Clinical Understanding of the Human Gut Microbiome. Clinical Understanding of the Human Gut Microbiome
83
96
.
Wenxi Jiang, Jiali Wu, Shefeng Zhu, Linying Xin, Chaohui Yu & Zhe Shen. (2022) The Role of Short Chain Fatty Acids in Irritable Bowel Syndrome. Journal of Neurogastroenterology and Motility 28:4, pages 540-548.
Crossref
Crossref
Harrison Hamblin, Anoja W. Gunaratne, Annabel Clancy, Denise Pilarinos, Antoinette LeBusque, Marie Vic M. Dawson & Thomas J. Borody. (2022) Pre-Antibiotic Treatment Followed by Prolonged Repeated Faecal Microbiota Transplantation Improves Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome: An Observational Australian Clinical Experience. Gastroenterology Research and Practice 2022, pages 1-17.
Crossref
Crossref
Tarek Mazzawi, Trygve Hausken, Per Førde Refsnes, Jan Gunnar Hatlebakk & Gülen Arslan Lied. (2022) The Effect of Anaerobically Cultivated Human Intestinal Microbiota Compared to Fecal Microbiota Transplantation on Gut Microbiota Profile and Symptoms of Irritable Bowel Syndrome, a Double-Blind Placebo-Controlled Study. Microorganisms 10:9, pages 1819.
Crossref
Crossref
Yomna Ali Abdelghafar, Yossef Hassan AbdelQadir, Karam R. Motawea, Sara Amr Nasr, Hoda Aly Mohamed Omran, Mohamed Mohamed Belal, Mohamed Mahdy Elhashash, Ahmed Alaa AbdelAzim & Jaffer Shah. (2022) Efficacy and safety of fecal microbiota transplant in irritable bowel syndrome: An update based on meta‐analysis of randomized control trials. Health Science Reports 5:5.
Crossref
Crossref
Ashenafi Feyisa Beyi, Michael Wannemuehler & Paul J. Plummer. (2022) Impacts of Gut Microbiota on the Immune System and Fecal Microbiota Transplantation as a Re-Emerging Therapy for Autoimmune Diseases. Antibiotics 11:8, pages 1093.
Crossref
Crossref
Manuele Biazzo & Gabriele Deidda. (2022) Fecal Microbiota Transplantation as New Therapeutic Avenue for Human Diseases. Journal of Clinical Medicine 11:14, pages 4119.
Crossref
Crossref
Tarek Mazzawi. (2022) Gut Microbiota Manipulation in Irritable Bowel Syndrome. Microorganisms 10:7, pages 1332.
Crossref
Crossref
Kun Li, Zhibo Zeng, Juanjuan Liu, Lulu Pei, Yaping Wang, Aoyun Li, Muhammad Fakhar-e-Alam Kulyar, Muhammad Shahzad, Khalid Mehmood, Jiakui Li & Desheng Qi. (2022) Effects of Short-Chain Fatty Acid Modulation on Potentially Diarrhea-Causing Pathogens in Yaks Through Metagenomic Sequencing. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Cristina Iribarren, Lujain Maasfeh, Lena Öhman & Magnus Simrén. (2022) Modulating the gut microenvironment as a treatment strategy for irritable bowel syndrome: a narrative review. Gut Microbiome 3.
Crossref
Crossref
Philip Augustine, Uday Chand Ghoshal, Rizwan Ahamed Zulfikar & Cyriac Abby Philips. 2022. Human Microbiome. Human Microbiome
55
71
.
Jun-Jie Hou, Xin Wang, Ying Li, Shuai Su, Yu-Ming Wang & Bang-Mao Wang. (2021) The relationship between gut microbiota and proteolytic activity in irritable bowel syndrome. Microbial Pathogenesis 157, pages 104995.
Crossref
Crossref
Bani Ahluwalia, Cristina Iribarren, Maria K. Magnusson, Johanna Sundin, Egbert Clevers, Otto Savolainen, Alastair B. Ross, Hans Törnblom, Magnus Simrén & Lena Öhman. (2021) A Distinct Faecal Microbiota and Metabolite Profile Linked to Bowel Habits in Patients with Irritable Bowel Syndrome. Cells 10:6, pages 1459.
Crossref
Crossref
Tarek Mazzawi, Magdy El-Salhy, Gülen Arslan Lied & Trygve Hausken. (2021) The Effects of Fecal Microbiota Transplantation on the Symptoms and the Duodenal Neurogenin 3, Musashi 1, and Enteroendocrine Cells in Patients With Diarrhea-Predominant Irritable Bowel Syndrome. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Wenyan Wu, Nan Shen, Lijuan Luo, Zhaohui Deng, Jing Chen, Yue Tao, Xi Mo & Qing Cao. (2021) Fecal microbiota transplantation before hematopoietic stem cell transplantation in a pediatric case of chronic diarrhea with a FOXP3 mutation. Pediatrics & Neonatology 62:2, pages 172-180.
Crossref
Crossref
S. HolsterD. RepsilberD. GengT. HyötyläinenA. SalonenC.M. LindqvistS.K. RajanW.M. de VosR.J. BrummerJ. König. (2021) Correlations between microbiota and metabolites after faecal microbiota transfer in irritable bowel syndrome. Beneficial Microbes 12:1, pages 17-30.
Crossref
Crossref
Zhenyi Tian, Xiaojun Zhuang, Mei Luo, Wei Yin & Lishou Xiong. (2020) The propionic acid and butyric acid in serum but not in feces are increased in patients with diarrhea-predominant irritable bowel syndrome. BMC Gastroenterology 20:1.
Crossref
Crossref
Raphael Watt, Kimberley Parkin & David Martino. (2020) The Potential Effects of Short-Chain Fatty Acids on the Epigenetic Regulation of Innate Immune Memory. Challenges 11:2, pages 25.
Crossref
Crossref
Caterina Carco, Wayne Young, Richard B. Gearry, Nicholas J. Talley, Warren C. McNabb & Nicole C. Roy. (2020) Increasing Evidence That Irritable Bowel Syndrome and Functional Gastrointestinal Disorders Have a Microbial Pathogenesis. Frontiers in Cellular and Infection Microbiology 10.
Crossref
Crossref
Herbert L. DuPont, Zhi-Dong Jiang, Andrew W. DuPont & Netanya S. Utay. (2020) Abnormal Intestinal Microbiome in Medical Disorders and Potential Reversibility by Fecal Microbiota Transplantation. Digestive Diseases and Sciences 65:3, pages 741-756.
Crossref
Crossref
Tarek Mazzawi, Øystein Eikrem, Gülen Arslan Lied & Trygve Hausken. (2020) Abnormal Uroguanylin Immunoreactive Cells Density in the Duodenum of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Changes following Fecal Microbiota Transplantation. Gastroenterology Research and Practice 2020, pages 1-9.
Crossref
Crossref
Andrew Canakis, Mustafa Haroon & H. Christian Weber. (2020) Irritable bowel syndrome and gut microbiota. Current Opinion in Endocrinology, Diabetes & Obesity 27:1, pages 28-35.
Crossref
Crossref